Science Explorer Back to mapMap
Discussion
Company · Vancouver · Canada

Acuitas Therapeutics (Canada)

acuitastx.comROR OpenAlex
Research works
51
▲ 144% vs 2018-21
Citations
5.7k
111.2 per fractional work
Top-10% rate
42.0%
all institutions 10.0%
Open access
74%
world 40%
International
80%
world 18%
Acuitas Therapeutics (Canada)

Not ranked overall: Acuitas Therapeutics (Canada) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Acuitas Therapeutics (Canada) work in?

In 2022-now, 47% of research at Acuitas Therapeutics (Canada) is in Life Sciences, 46% in Health Sciences. Its largest fields are Medicine (46%), Biochemistry, Genetics and Molecular Biology (19%), Immunology and Microbiology (18%). It does 2.4× the world's share of Life Sciences.

Life Sciences: 13 fractional works · 46.9% of its workBiochemistry, Genetics and Molecular Biology: 5 fractional works · 19.0% of its workMolecular Biology: 4 fractional works · 15.1% of its workGenetics: 1 fractional works · 3.1% of its workCell Biology: 0 fractional works · 0.6% of its workClinical Biochemistry: 0 fractional works · 0.3% of its workImmunology and Microbiology: 5 fractional works · 17.8% of its workImmunology: 4 fractional works · 14.4% of its workVirology: 1 fractional works · 2.0% of its workParasitology: 0 fractional works · 1.2% of its workMicrobiology: 0 fractional works · 0.3% of its workAgricultural and Biological Sciences: 2 fractional works · 8.2% of its workAnimal Science and Zoology: 2 fractional works · 6.2% of its workEcology, Evolution, Behavior and Systematics: 0 fractional works · 1.1% of its workInsect Science: 0 fractional works · 0.8% of its workNeuroscience: 0 fractional works · 1.8% of its workNeurology: 0 fractional works · 1.5% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.3% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.1% of its workHealth Sciences: 12 fractional works · 45.6% of its workMedicine: 12 fractional works · 45.6% of its workInfectious Diseases: 5 fractional works · 17.4% of its workEpidemiology: 2 fractional works · 7.5% of its workOncology: 1 fractional works · 3.4% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 2.9% of its workGenetics: 1 fractional works · 2.1% of its workHepatology: 0 fractional works · 1.6% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 1.6% of its workObstetrics and Gynecology: 0 fractional works · 1.4% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 1.4% of its workSurgery: 0 fractional works · 1.4% of its workHematology: 0 fractional works · 1.4% of its workPhysiology: 0 fractional works · 0.9% of its workPathology and Forensic Medicine: 0 fractional works · 0.5% of its workNeurology: 0 fractional works · 0.4% of its workUrology: 0 fractional works · 0.4% of its workAnesthesiology and Pain Medicine: 0 fractional works · 0.3% of its workPharmacology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.7% of its workPhysical Sciences: 2 fractional works · 7.1% of its workEngineering: 1 fractional works · 3.4% of its workElectrical and Electronic Engineering: 1 fractional works · 2.1% of its workBiomedical Engineering: 0 fractional works · 0.7% of its workComputational Mechanics: 0 fractional works · 0.6% of its workChemistry: 0 fractional works · 1.8% of its workOrganic Chemistry: 0 fractional works · 0.6% of its workPhysical and Theoretical Chemistry: 0 fractional works · 0.6% of its workSpectroscopy: 0 fractional works · 0.6% of its workComputer Science: 0 fractional works · 1.2% of its workComputational Theory and Mathematics: 0 fractional works · 1.2% of its workEnvironmental Science: 0 fractional works · 0.7% of its workEcology: 0 fractional works · 0.7% of its workSocial Sciences: 0 fractional works · 0.4% of its workSocial Sciences: 0 fractional works · 0.4% of its workHealth: 0 fractional works · 0.4% of its workALL ITS WORKAcuitasTherapeutics…27fractional works, 2022-now
Life Sciences47%Physical Sciences7%Health Sciences46%Social Sciences0%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 11 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology519.0%
    2. Immunology and Microbiology517.8%
    3. Agricultural and Biological Sciences28.2%
    4. Neuroscience01.8%
    5. Pharmacology, Toxicology and Pharmaceutics00.1%
    1. Medicine1245.6%
    1. Engineering13.4%
    2. Chemistry01.8%
    3. Computer Science01.2%
    4. Environmental Science00.7%
    1. Social Sciences00.4%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 1.72× its world share, 2 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.57× its world share, 5 worksBiochemistry, Geneti…Immunology and Microbiology: 17.70× its world share, 5 worksImmunology and Micro…Neuroscience: 1.09× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 0.39× its world share, 0 worksPharmacology, Toxico…Chemistry: 1.17× its world share, 0 worksChemistryComputer Science: 0.16× its world share, 0 worksComputer ScienceEngineering: 0.22× its world share, 1 worksEngineeringEnvironmental Science: 0.13× its world share, 0 worksEnvironmental ScienceMedicine: 2.37× its world share, 12 worksMedicineSocial Sciences: 0.03× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 17.7×. Every wedge is a field page.

All 11 fields, with their numbers
  1. Immunology and Microbiology17.70×5 works
  2. Biochemistry, Genetics and Molecular Biology3.57×5 works
  3. Medicine2.37×12 works
  4. Agricultural and Biological Sciences1.72×2 works
  5. Chemistry1.17×0 works
  6. Neuroscience1.09×0 works
  7. Pharmacology, Toxicology and Pharmaceutics0.39×0 works
  8. Engineering0.22×1 works
  9. Computer Science0.16×0 works
  10. Environmental Science0.13×0 works
  11. Social Sciences0.03×0 works

Who are the top researchers at Acuitas Therapeutics (Canada)?

Ranked on the quality score, Ying K. Tam, Barbara L. Mui and Paulo J.C. Lin lead among researchers whose main affiliation is Acuitas Therapeutics (Canada).

  1. 1 Ying K. Tam Canada · #5,916 worldwide 23k citations · 192 works
  2. 2 Barbara L. Mui Canada · #17,217 worldwide 15k citations · 59 works
  3. 3 Paulo J.C. Lin Canada · #33,979 worldwide 7.1k citations · 99 works
  4. 4 Christopher Barbosa Canada · #433,956 worldwide 1.8k citations · 25 works
  5. 5 Steven H.Y. Fan Canada · #687,205 worldwide 1.9k citations · 18 works
  6. 6 Molly M. H. Sung Canada · #1,107,129 worldwide 679 citations · 19 works
All ranked researchers at Acuitas Therapeutics (Canada)

What are the most cited papers from Acuitas Therapeutics (Canada)?

The most cited paper from Acuitas Therapeutics (Canada) is "The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs" (Akin Akinc, Martin A. Maier, Muthiah A. Manoharan et al., 2019), with 1,651 citations. Next come "CAR T cells produced in vivo to treat cardiac injury" (1,352) and "Lipid Nanoparticle Systems for Enabling Gene Therapies" (1,190).

Most cited papers
#PaperReleasedCitations
1 The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs Akin Akinc, Martin A. Maier, Muthiah A. Manoharan et al. · Nature Nanotechnology Open access Dec 2019 1,651
2 CAR T cells produced in vivo to treat cardiac injury Joel G. Rurik, István Tombácz, Amir Yadegari et al. · Science Open access 6 Jan 2022 1,352
3 Lipid Nanoparticle Systems for Enabling Gene Therapies Pieter R. Cullis, Michael J. Hope · Molecular Therapy Open access 13 Apr 2017 1,190
4 Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes Norbert Pardi, Steven Tuyishime, Hiromi Muramatsu et al. · Journal of Controlled Release Open access 8 Aug 2015 1,054
5 Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination Norbert Pardi et al. · Nature Open access 2 Feb 2017 903
All 59 most cited papers, with filters and sorting

Which keywords describe research at Acuitas Therapeutics (Canada)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Epidemiology, Vaccine, Pathogenesis, Coronavirus, Immunity, Immune Response, Pandemic and SARS-CoV-2.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 28 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 28 words, with their numbers
  1. Epidemiology8▲ 6.9×22 topics
  2. Vaccine7▲ 62×8 topics
  3. Pathogenesis4▲ 32×6 topics
  4. Coronavirus4▲ 76×2 topics
  5. Immunity4▲ 36×2 topics
  6. Immune Response4▲ 25×10 topics
  7. Pandemic3▲ 12×3 topics
  8. SARS-CoV-23▲ 36×3 topics
  9. ACE2 Receptor3▲ 43×2 topics
  10. Gene Therapy3▲ 49×2 topics
  11. Innate Immunity2▲ 28×5 topics
  12. Viral Transmission2▲ 67×2 topics
  13. Cancer Immunotherapy2▲ 58×3 topics
  14. antibody2▲ 90×1 topic
  15. spike protein2▲ 90×1 topic
  16. RNA Interference2▲ 87×1 topic
  17. siRNA Delivery2▲ 125×1 topic
  18. Antigen Presentation2▲ 78×2 topics
  19. Metagenomics2▲ 75×2 topics
  20. Genomic Sequencing2▲ 57×3 topics
  21. Circovirus2▲ 203×1 topic
  22. Porcine Reproductive and Respiratory Syndrome Virus2▲ 203×1 topic
  23. Dendritic Cells2▲ 65×1 topic
  24. Tumor Antigen2▲ 95×1 topic
  25. Infection1▲ 21×2 topics
  26. Norovirus1▲ 96×1 topic
  27. Oxidative Stress1▲ 2.4×7 topics
  28. Rotavirus1▲ 96×1 topic

Which research topics does Acuitas Therapeutics (Canada) publish most on?

By volume in 2022-now: SARS-CoV-2 and COVID-19 Research, RNA Interference and Gene Delivery, Animal Virus Infections Studies and Immunotherapy and Immune Responses.

SARS-CoV-2 and COVID-19 Research: 2 fractional worksRNA Interference and Gene Delivery: 2 fractional worksAnimal Virus Infections Studies: 2 fractional worksImmunotherapy and Immune Responses: 2 fractional worksViral gastroenteritis research and epidemiology: 1 fractional worksCAR-T cell therapy resea…1CAR-T cell therapy research: 1 fractional worksMonoclonal and Polyclonal Antibodies Research: 1 fractional worksHerpesvirus Infections and Treatments: 1 fractional worksVirus-based gene therapy research: 1 fractional worksImmune Cell Function and Interaction: 1 fractional works
Infectious DiseasesMolecular BiologyAnimal Science and ZoologyImmunology4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 SARS-CoV-2 and COVID-19 Research Infectious Diseases 2 works
  2. 2 RNA Interference and Gene Delivery Molecular Biology 2 works
  3. 3 Animal Virus Infections Studies Animal Science and Zoology 2 works
  4. 4 Immunotherapy and Immune Responses Immunology 2 works
  5. 5 Viral gastroenteritis research and epidemiology Infectious Diseases 1 works
  6. 6 CAR-T cell therapy research Oncology 1 works
  7. 7 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  8. 8 Herpesvirus Infections and Treatments Epidemiology 1 works
  9. 9 Virus-based gene therapy research Genetics 1 works
  10. 10 Immune Cell Function and Interaction Immunology 1 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available73.8%not open26.2%

World: 40% of research is openly available.

with international co-authors79.6%domestic only20.4%

World: 18% is written across borders.

How has Acuitas Therapeutics (Canada)'s research output changed?

Output in 2022-2025 was 144% higher than in 2018-2021.

still counting20052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Acuitas Therapeutics (Canada) as a percentage of every work published that year, 0.00012% in 2024.

still counting0.000050%0.00010%0.00015%Acuitas Therapeutics (Canada)0.000095% in 202520102020

Fractional works of Acuitas Therapeutics (Canada) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Vancouver

All research institutions in Vancouver

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Acuitas Therapeutics (Canada). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.